Woolley J L, Sigel C W
Drug Metab Dispos. 1979 Mar-Apr;7(2):94-9.
The tissue distribution and metabolism of 35S-sulfadiazine (I, SDZ) alone and in the presence of trimethoprim (TMP) was studied in the male rat. In the 72-hr period following a single oral dose (30 mg/kg) of 35S-SDZ/TMP (5/1, w/w), 87% of the radioactivity was recovered in the urine and 15% of the radioactivity was recovered in the feces. The concentrations of drug-related material in the plasma or tissues after 72 hr were less than 0.1 ppm with the exception of the liver (0.13 ppm). Aside from intact drug, the two major urinary metabolites (greater than 5% of the radioactivity in urine) were N4-acetylsulfadiazine (II) and sulfadiazine N4-glucuronide (VI). Three minor urinary metabolites (less than 5%) were identified as N4-acetyl-2-sulfanilamido-4-hydroxypyrimidine (IV), 2-sulfanilamido-4-hydroxypyrimidine (III) and 2-sulfanilamido-5-hydroxypyrimidine (V). Metabolites IV and V are novel metabolites of SDZ and have not been reported previously for any species. The relative amounts of sulfadiazine and its metabolites excreted in the urine and feces as well as the distribution of intact drug and 35S in rat tissues were determined. The metabolites were screened for antibacterial activity; the N4-acetylated metabolites II and IV were inactive, whereas the hydroxypyrimidine metabolites III and V were active against a few organisms but in general much less active than I.
在雄性大鼠中研究了单独的35S - 磺胺嘧啶(I,SDZ)以及在甲氧苄啶(TMP)存在下的组织分布和代谢情况。在单次口服剂量(30mg/kg)的35S - SDZ/TMP(5/1,w/w)后的72小时内,87%的放射性在尿液中回收,15%的放射性在粪便中回收。72小时后,除肝脏(0.13ppm)外,血浆或组织中与药物相关物质的浓度低于0.1ppm。除了完整药物外,两种主要的尿液代谢物(占尿液中放射性的5%以上)是N4 - 乙酰磺胺嘧啶(II)和磺胺嘧啶N4 - 葡萄糖醛酸苷(VI)。三种次要的尿液代谢物(低于5%)被鉴定为N4 - 乙酰 - 2 - 磺胺氨基 - 4 - 羟基嘧啶(IV)、2 - 磺胺氨基 - 4 - 羟基嘧啶(III)和2 - 磺胺氨基 - 5 - 羟基嘧啶(V)。代谢物IV和V是SDZ的新型代谢物,此前尚未在任何物种中报道过。测定了磺胺嘧啶及其代谢物在尿液和粪便中的排泄相对量以及完整药物和35S在大鼠组织中的分布。对代谢物的抗菌活性进行了筛选;N4 - 乙酰化代谢物II和IV无活性,而羟基嘧啶代谢物III和V对少数生物体有活性,但总体上比I活性低得多。